Gileads Kite bags second CAR-T okay with Tecartus nod in mantle cell lymphoma
Kite, a Gilead Company announced that the U.S. FDA has granted accelerated approval to Tecartus™ (brexucabtagene autoleucel, formerly KTE-X19), the first and only approved...
Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir in Patients with Mild to Moderate COVID-19
Glenmark Pharmaceuticals Ltd. a global research-led pharmaceutical company announced top-line results from a Phase 3 clinical trial in mild to moderate COVID-19 patients conducted...
US doubles COVID vaccine fund as Moderna enters final phase of clinical trial
The United States has doubled its investment to nearly $1 billion to expedite development of a potential COVID-19 vaccine by American firm Moderna, which...
FDA Approves Expanded BOTOX Label for the Treatment of Pediatric Patients with Spasticity
Allergan, an AbbVie company, announced that the U.S. FDA approved a supplemental Biologics License Application (sBLA) that supports expanded use of BOTOX® for the...
Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer
AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) has been approved in the European Union (EU) for patients with germline BRCA-mutated...
AstraZeneca’s Farxiga scores another FDA fast-track designation
AstraZeneca’s heart failure drug Farxiga has picked up a US FDA fast-track designation (FTD) in another indication as it continues to strengthen its position...
Boehringer Ingelheim gets European approval for additional indication for nintedanib in pulmonary fibrosis
Boehringer Ingelheim announced that the EC has approved an additional indication for nintedanib in adults for the treatment of other chronic fibrosing interstitial lung...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...